investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Characterizing MSI2 in leukemia

Michael Kharas

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Andrew A Lane

Targeting Chromatin Modifications in Leukemia with Trisomy 21

Leukaemia

Peter Aplan

Pre-clinical Studies of Therapy for Myelodysplastic Syndrome

Leukaemia

Hematology and hematologic malignancies

David A Scheinberg

Mechanisms of action of a TCR-like antibody to WT1

Leukaemia

Ya-Huei Kuo

HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance

Leukaemia

Pathology Hematology and hematologic malignancies

Benjamin Levine Ebert

Development of Novel Therapeutic Strategies in Human Leukemias

Leukaemia

Edward W Harhaj

Mechanisms of HTLV-I Tax Mediated NF-kB Activation

Leukaemia

Pathology Hematology and hematologic malignancies

Mark Y Chiang

Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia

Leukaemia

Hematology and hematologic malignancies

Julie Aurore Losman

The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia

Leukaemia

Dan Landau

The role of epigenetic heterogeneity in CLL evolution

Leukaemia